سعر ماسيريبيست 0.05%كريم 15جم 2022

Macerybest 0.05% cream 15 g (Egypt; Al Esraa Pharmaceutical / Optima): topical fluocinonide 0.05%, a potent corticosteroid for corticosteroid-responsive dermatoses.

• Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.DailyMed (U.S. National Library of Medicine)

• Local reactions reported infrequently: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis; more frequently with occlusion: maceration, secondary infection, skin atrophy, striae and miliaria.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• History of hypersensitivity to any of the components of the preparation.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Systemic absorption can cause reversible HPA-axis suppression, manifestations of Cushing's syndrome, hyperglycemia and glucosuria, especially with large areas, prolonged use or occlusion; children are more susceptible and intracranial hypertension has been reported in children.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Topical corticosteroids should not be used extensively on pregnant patients, in large amounts, or for prolonged periods; use only if the potential benefit justifies the potential risk to the fetus.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Caution should be exercised when topical corticosteroids are administered to a nursing woman.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Fluocinonide: Topical corticosteroids have anti-inflammatory, antipruritic and vasoconstrictive actions; the mechanism is thought to involve induction of phospholipase A2 inhibitory proteins (lipocortins) that control mediators such as prostaglandins and leukotrienes.